Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Classical hematology 1

Conditions

Anemia 4Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Primary Myelofibrosis 1Neoplasms 1Neoplasm Metastasis 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 29fludarabine phosphate 27Mycophenolic Acid 21Peripheral Blood Stem Cell Transplantation 18Whole-Body Irradiation 17Cyclosporine 16Busulfan 15Tacrolimus 14Antilymphocyte Serum 12Melphalan 11Filgrastim 11fludarabine 10Cord Blood Stem Cell Transplantation 10Radiotherapy 7Methotrexate 7Methylprednisolone 6Etoposide 6Stem Cell Transplantation 4Cytarabine 4thymoglobulin 3Thiotepa 3Sirolimus 3Hematopoietic Stem Cell Transplantation 3Granulocyte Colony-Stimulating Factor 3Cyclosporins 3Alemtuzumab 3ruxolitinib 2luspatercept 2Specimen Handling 2Leucovorin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Primary Myelofibrosis × ACE-011 × Classical hematology × Clear all
NCT01712308 2023-10-10

Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia

M.D. Anderson Cancer Center

Phase 2 Completed
56 enrolled 9 charts
Classical hematologyMyeloid

Anemia, Myelodysplastic-Myeloproliferative Diseases, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡